Human Stem Cells Institute (ISKJ) - Financial and Strategic SWOT Analysis Review

  • ID: 4284653
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 4
Summary

Human Stem Cells Institute (HSCI) is a biotech company that provides discovery, research and development, and marketing of proprietary products and services in the areas of regenerative medicine, medical genetics, bio-insurance, gene therapy and biopharmaceutics. The company offers neovasculgen, a gene-therapy drug for treatment of peripheral arterial disease including critical limb ischemia; and SPRS-therapy, a set of personalized diagnostics and treatment procedures for repairing skin damage. Its neovasculgen is a gene-therapy drug, which is used in the treatment of peripheral arterial disease. HSCI also provides gemacell, a cell-based drug candidate for the treatment of myocardial infarction; and prenetix, a non-invasive prenatal diagnosis of fetal chromosome abnormalities. It owns and operates a reproductive cell and tissue bank for personal storage and donation. HSCI is headquartered in Moscow, Russia.

Human Stem Cells Institute Key Recent Developments

Dec 01, 2017: HSCI Announces 9 Months 2017 Consolidated Results under IFRS
Aug 29, 2017: HSCI Announces H1 2017 Consolidated Results Under IFRS

This comprehensive SWOT profile of Human Stem Cells Institute provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Human Stem Cells Institute including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Human Stem Cells Institute - Key Information
  • Human Stem Cells Institute - Overview
  • Human Stem Cells Institute - Key Employees
  • Human Stem Cells Institute - Key Employee Biographies
  • Human Stem Cells Institute - Key Operational Heads
  • Human Stem Cells Institute - Major Products and Services
  • Human Stem Cells Institute - History
  • Human Stem Cells Institute - Company Statement
  • Human Stem Cells Institute - Locations And Subsidiaries
  • Human Stem Cells Institute - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Human Stem Cells Institute - Business Description
  • Human Stem Cells Institute - Corporate Strategy
  • Human Stem Cells Institute - SWOT Analysis
  • SWOT Analysis - Overview
  • Human Stem Cells Institute - Strengths
  • Human Stem Cells Institute - Weaknesses
  • Human Stem Cells Institute - Opportunities
  • Human Stem Cells Institute - Threats
  • Human Stem Cells Institute - Key Competitors
Section 3 - Company Financial Performance Charts
  • Human Stem Cells Institute - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Human Stem Cells Institute, Key Information
  • Human Stem Cells Institute, Key Ratios
  • Human Stem Cells Institute, Share Data
  • Human Stem Cells Institute, Major Products and Services
  • Human Stem Cells Institute, History
  • Human Stem Cells Institute, Key Employees
  • Human Stem Cells Institute, Key Employee Biographies
  • Human Stem Cells Institute, Key Operational Heads
  • Human Stem Cells Institute, Other Locations
  • Human Stem Cells Institute, Subsidiaries
  • Human Stem Cells Institute, Key Manufacturing facilities
  • Human Stem Cells Institute, Key Competitors
  • Human Stem Cells Institute, SWOT Analysis
  • Human Stem Cells Institute, Ratios based on current share price
  • Human Stem Cells Institute, Annual Ratios
  • Human Stem Cells Institute, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Human Stem Cells Institute, Performance Chart
  • Human Stem Cells Institute, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll